Ceritinib/ceritinib domestic market price and pharmacy purchase reference

Ceritinib (Ceritinib) is an oral ALK inhibitor, mainly used to treat ALK-positive non-small cell lung cancer (NSCLC) patients. In the domestic market, ceritinib has been officially launched and has been included in the medical insurance system, which means that eligible patients can reimburse part of the drug cost through medical insurance, thereby reducing the financial burden. Since the drug is a prescription drug, purchase must be under the guidance of a doctor.

In terms of domestic purchase channels, patients can mainly obtain ceritinib through regular hospital pharmacies. The medicines provided by the hospital pharmacy are from reliable sources and of guaranteed quality. They can also provide medication guidance and personalized dosage adjustment suggestions based on the patient's condition. When purchasing, you need to have a prescription from a doctor and complete the purchase process at the pharmacy.

In terms of price, the price of domestic original drug ceritinib is relatively high due to factors such as imported drug cost, transportation and brand premium. The specific price and medical insurance reimbursement ratio will vary depending on the region and medical insurance policy. Therefore, patients need to consult the local hospital pharmacy to learn about the latest prices and reimbursement plans in order to reasonably arrange treatment costs.

For patients with limited financial conditions or who want to reduce treatment costs, foreign generic drugs are a viable option. The current price of the Lao version of ceritinib is around more than 1,000 yuan, and the drug ingredients are basically the same as the domestic original drug, which can meet the needs of clinical treatment. However, when choosing overseas generic drugs, you should ensure that the channels are formal and avoid purchasing fake or inferior drugs to ensure drug safety and efficacy.

Reference materials:https://www.drugs.com/